Peptide library
AICAR
Your guide to this compound.
Dose context
Research context only; no personal regimen.
Historical CABG research used a continuous IV infusion of 0.05 or 0.1 mg/kg/min for 7 hours, plus acadesine in cardioplegia. These are infusion rates in a surgical trial, not bolus doses or a subcutaneous regimen.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
A human IV disposition study exists, but no numeric half-life is supplied here until its full pharmacokinetic methods and analyte are reviewed.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
No validated route or schedule recorded.
Storage
No exact commercial formulation or validated storage period was established by the sources reviewed here. Do not infer a refrigerated shelf life or beyond-use date for a seller’s vial.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
No product-specific human-use preparation instructions were verified in this review.